FDA.reportPublic FDA data

ASPARTAME

Substance profile for UNII Z0H242BBR1, enriched with FDA NDC listings, DailyMed labels, legacy aliases, and open chemistry identifiers.

Chemical structure for ASPARTAME
Structure render from NCI/CADD chemical resolver

Substance Identity#

UNII
Z0H242BBR1
Preferred term
ASPARTAME
Registry number
22839-47-0
EC number
245-261-3
Ingredient type
INGREDIENT SUBSTANCE
Molecular formula
C14H18N2O5
Chemical structure for ASPARTAME
Structure render from NCI/CADD chemical resolver

Chemical And Database Identifiers#

InChIKey
IAOZJIPTCAWIRG-QWRGUYRKSA-N
SMILES
COC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](N)CC(O)=O
RxCUI
1311524
PubChem
0
NCIt
C76513
INN ID
3019

Open Chemistry Sources#

Source, Identifier, Link table
SourceIdentifierLink
PubChem InChIKey SearchIAOZJIPTCAWIRG-QWRGUYRKSA-Nhttps://pubchem.ncbi.nlm.nih.gov/#query=IAOZJIPTCAWIRG-QWRGUYRKSA-N
RxNorm1311524https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=1311524
NCI ThesaurusC76513https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C76513
FDA Substance Registration SystemZ0H242BBR1https://precision.fda.gov/uniisearch/srs/unii/Z0H242BBR1
European Community number245-261-3https://commonchemistry.cas.org/results?q=245-261-3

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR124fdfded-5d47-07a4-e054-00144ff8d46c2
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1These highlights do not include all the information needed to use MONTELUKAST SODIUM CHEWABLE TABLETS safely and effectively. See full prescribing information for MONTELUKAST SODIUM CHEWABLE TABLETS. Montelukast Sodium Chewable Tablets, for oral use Initial U.S. Approval: 19982
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts3
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1These highlights do not include all the information needed to use MONTELUKAST SODIUM TABLETS and MONTELUKAST SODIUM CHEWABLE TABLETS safely and effectively. See full prescribing information for MONTELUKAST SODIUM TABLETS and MONTELUKAST SODIUM CHEWABLE TABLETS. Montelukast Sodium Tablets, for oral use. Montelukast Sodium Chewable Tablets, for oral use. Initial U.S. Approval: 19983
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1AMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION, USP 600 mg/42.9 mg per 5 mL1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Ondansetron Orally Disintegrating Tablets5
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1ONDANSETRON4
aspartameINACTIVE INGREDIENTZ0H242BBR1Kroger ® DayTime Flu + Severe Cold & Cough2
aspartameINACTIVE INGREDIENTZ0H242BBR1Kroger ® NiteTime Flu + Severe Cold & Cough2
ASPARTAMEACTIVE MOIETYZ0H242BBR1DRUG FACTS:2
ASPARTAMEACTIVE INGREDIENTZ0H242BBR1DRUG FACTS:2
aspartameINACTIVE INGREDIENTZ0H242BBR1Rite Aid ® Daytime Severe Cold & Cough Relief2
aspartameINACTIVE INGREDIENTZ0H242BBR1Rite Aid ® Nighttime Severe Cold & Cough Relief2
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts3
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
aspartameINACTIVE INGREDIENTZ0H242BBR1ShopRite ® DayTime Flu + Severe Cold & Cough1
aspartameINACTIVE INGREDIENTZ0H242BBR1ShopRite ® Nighttime Flu + Severe Cold & Cough1
ASPARTAMEACTIVE MOIETYZ0H242BBR1DRUG FACTS:2
ASPARTAMEACTIVE INGREDIENTZ0H242BBR1DRUG FACTS:2
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Ondansetron Orally Disintegrating Tablets, USP Rx only2
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Ondansetron Orally Disintegrating Tablets, USP Rx only2
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBrand Phenylephrine HCl1
AspartameINACTIVE INGREDIENTZ0H242BBR1TopCare Daytime Severe Cold and Cough Berry infused with Menthol and Green Tea flavors2
AspartameINACTIVE INGREDIENTZ0H242BBR1Topcare Nighttime Severe Cold and Cough Honey lemon infused with Chamomile and White tea flavors2
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Amoxicillin and Clavulanate Potassium 600 mg/42.9 mg per 5 mL Powder for Oral Suspension1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Ondansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Travel Sickness3
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1PRESCRIBING INFORMATION ONDANSETRON ORALLY DISINTEGRATING TABLETS, USP Rx only3
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Amoxicillin and Clavulanate Potassium 600 mg/42.9 mg per 5 mL Powder for Oral Suspension2
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1These highlights do not include all the information needed to use amoxicillin and clavulanate potassium for oral suspension, USP safely and effectively. See full prescribing information for amoxicillin and clavulanate potassium for oral suspension, USP. Amoxicillin and Clavulanate Potassium for Oral Suspension, USP Initial U.S. Approval: 1984 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium for oral suspension and other antibacteria1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1These highlights do not include all the information needed to use amoxicillin and clavulanate potassium for oral suspension, USP safely and effectively. See full prescribing information for amoxicillin and clavulanate potassium for oral suspension, USP. Amoxicillin and Clavulanate Potassium for Oral Suspension, USP Initial U.S. Approval: 1984 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium for oral suspension and other antibacteria1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1These highlights do not include all the information needed to use amoxicillin and clavulanate potassium for oral suspension, USP safely and effectively. See full prescribing information for amoxicillin and clavulanate potassium for oral suspension, USP. Amoxicillin and Clavulanate Potassium for Oral Suspension, USP Initial U.S. Approval: 1984 To reduce the development of drug-resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium for oral suspension and other antibacteria1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Perrigo Junior Strength Ibuprofen Tablets, 100 mg Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1These highlights do not include all the information needed to use olanzapine orally disintegrating tablets safely and effectively. See full prescribing information for olanzapine orally disintegrating tablets. Olanzapine Orally Disintegrating Tablets for Oral use Initial U.S. Approval: 19962
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1CLARITHROMYCIN TABLETS, USP AND CLARITHROMYCIN FOR ORAL SUSPENSION, USP Rx only4
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1AMOXICILLIN AND CLAVULANATE POTASSIUM FOR ORAL SUSPENSION, USP, 600 mg/42.9 mg per 5 mL Rx only2
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1CEFUROXIME AXETIL FOR ORAL SUSPENSION,USP Rx Only1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Perrigo Tussin DM Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1CVS Pharmacy Daytime Nighttime Severe Cold & Cough Kit3
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
AspartameINACTIVE INGREDIENTZ0H242BBR1d2b9e29f-7cc8-470b-9546-9614f8eda1991
AspartameINACTIVE INGREDIENTZ0H242BBR1CVS Pharmacy Daytime Severe Cough and Cold Berry infused with Menthol and Green Tea flavors2
AspartameINACTIVE INGREDIENTZ0H242BBR1CVS Pharmacy Nighttime Severe Cough and Cold Honey lemon infused with Chamomile and White tea flavors4
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
aspartameINACTIVE INGREDIENTZ0H242BBR1Once-A-Day Mirtazapine Orally Disintegrating Tablets1
aspartameINACTIVE INGREDIENTZ0H242BBR1CVS Natural Fiber Effervescent1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR16f6f3aae-a676-4b91-bad3-2a1c798ffe0a1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1These highlights do not include all the information needed to use rizatriptan benzoate orally disintegrating tablets safely and effectively. See full prescribing information for rizatriptan benzoate orally disintegrating tablets. Rizatriptan Benzoate Orally Disintegrating Tablets Initial U.S. Approval: 19981
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Scot-Tussin Senior SF DMEXP5
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Scot-Tussin Expectorant SF Cough4
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1AUGMENTIN ES-600 ® Powder for Oral Suspension (amoxicillin/clavulanate potassium)1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1afbcbf79-e7cd-4615-a999-9941573882b52
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts3
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Sunmark Fiber Smooth texture Sugar free Orange flavor1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1These highlights do not include all the information needed to use montelukast sodium safely and effectively. See full prescribing information for montelukast sodium. MONTELUKAST SODIUM tablets and chewable tablets for oral use Initial U.S. Approval: 19982
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts5
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts2
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Amoxicillin and Clavulanate Potassium Powder for Oral Suspension and Chewable Tablets1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts2
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Health Mart Fiber powder Sugar free Orange flavor1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Ondansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Amerisource Bergen Junior Strength Ibuprofen Tablets, 100 mg Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Ondansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1These highlights do not include all the information needed to use Staxyn safely and effectively. See full prescribing information for Staxyn. STAXYN (vardenafil hydrochloride) orally disintegrating tablets Initial U.S. Approval: 20033
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1These highlights do not include all the information needed to use CAMBIA safely and effectively. See full prescribing information for CAMBIA. CAMBIA (Diclofenac Potassium for Oral Solution) Initial U.S. Approval: 19884
aspartameINACTIVE INGREDIENTZ0H242BBR1These highlights do not include all the information needed to use MAXALT and MAXALT-MLT safely and effectively. See full prescribing information for MAXALT and MAXALT-MLT. MAXALT (rizatriptan benzoate) tablets, for oral use MAXALT-MLT (rizatriptan benzoate) orally disintegrating tablets Initial U.S. Approval: 19982
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Perrigo Nicotine Polacrilex Lozenge 4 mg (nicotine) Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Perrigo Nicotine Lozenge Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR116ed3ca8-c85c-4d06-9c4f-d5bbf344b12e1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1These highlights do not include all the information needed to use olanzapine safely and effectively. See full prescribing information for olanzapine orally disintegrating tablets. Olanzapine Orally Disintegrating Tablets, for Oral use Initial U.S. Approval: 19964
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Acetaminophen Drug Facts1
aspartameINACTIVE INGREDIENTZ0H242BBR1These highlights do not include all the information needed to use SINGULAIR safely and effectively. See full prescribing information for SINGULAIR. SINGULAIR ® (montelukast sodium) Tablets, Chewable Tablets, and Oral Granules Initial U.S. Approval: 19981
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1These highlights do not include all the information needed to use APRISO safely and effectively. See full prescribing information for APRISO. APRISO™ (mesalamine) extended-release capsules Initial U.S. Approval: 19872
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1These highlights do not include all the information needed to use Welchol safely and effectively. See full prescribing information for Welchol. Welchol (colesevelam hydrochloride) Tablet, Film Coated, for Oral Welchol (colesevelam hydrochloride) For Suspension, for Oral Initial U.S. Approval: 20002
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Ondansetron Orally Disintegrating Tablets1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Ondansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP3
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Ondansetron Tablets USP Ondansetron Orally Disintegrating Tablets USP1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR108d06e6f-a1d8-4bd9-b851-d63858d55f912
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Amoxicillin and Clavulanate Potassium Powder for Oral Suspension, USP and Chewable Tablets, USP1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts2
AspartameACTIVE MOIETYZ0H242BBR1Allergies1
AspartameACTIVE INGREDIENTZ0H242BBR1Allergies1
AspartameACTIVE MOIETYZ0H242BBR1Allergies1
AspartameACTIVE INGREDIENTZ0H242BBR1Allergies1
AspartameACTIVE INGREDIENTZ0H242BBR1Food Allergy - Additive1
AspartameACTIVE MOIETYZ0H242BBR1Food Allergy - Additive1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1These highlights do not include all the information needed to use Welchol safely and effectively. See full prescribing information for Welchol. Welchol (colesevelam hydrochloride) Tablet, Film Coated, for Oral Welchol (colesevelam hydrochloride) For Suspension, for Oral Initial U.S. Approval: 20001
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1c6d3c1ff-d873-4903-befa-c0ba47034c6e1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR126b1d362-e727-49db-9e81-ee80ca97795c1
aspartameINACTIVE INGREDIENTZ0H242BBR1These highlights do not include all the information needed to use SINGULAIR safely and effectively. See full prescribing information for SINGULAIR. SINGULAIR ® (montelukast sodium) tablets, chewable tablets, and oral granules Initial U.S. Approval: 19981
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1These highlights do not include all the information needed to use lansoprazole delayed-release orally disintegrating tablets safely and effectively. See full prescribing information for lansoprazole delayed-release orally disintegrating tablets. LANSOPRAZOLE delayed-release orally disintegrating tablets for oral use Initial U.S. Approval: 19951
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Amoxicillin and Clavulanate Potassium2
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Drug Facts1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1Ondansetron Orally Disintegrating Tablets, USP2
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1a5fa252a-d39e-4099-a230-b665fbb97a801
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR12835b6f5-93da-4554-9d84-79132fd928ee1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1SINGULAIR® (MONTELUKAST SODIUM) TABLETS, CHEWABLE TABLETS, AND ORAL GRANULES1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1babf3b8d-f2ce-407d-9407-728c45eb19ee1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR16ca2803e-a4d6-4e57-a910-13237c93a4ce1
ASPARTAMEINACTIVE INGREDIENTZ0H242BBR1These highlights do not include all the information needed to use PREVACID safely and effectively. See full prescribing information for: PREVACID (lansoprazole) Delayed-Release Capsules PREVACID SoluTab (lansoprazole) Delayed-Release Orally Disintegrating Tablets For oral administration Initial U.S. Approval: 19952
AspartameINACTIVE INGREDIENTZ0H242BBR1night time wal-flu severe cold and cough honey lemon flavor infused with chamomile and white tea flavors8
AspartameINACTIVE INGREDIENTZ0H242BBR1Day time Severe Cold and Cough berry infused with menthol and green tea flavors3
AspartameINACTIVE INGREDIENTZ0H242BBR1night time severe cold and cough honey lemon infused with chamomile and white tea flavors3
AspartameINACTIVE INGREDIENTZ0H242BBR1Day time Cough and Severe Cold berry infused with menthol and green tea flavors7